SCHEMBL250456

SCHEMBL250456

CCNNC(=O)OCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL355253 0.84 GAA (0.55)
SCHEMBL12841650 0.81 GAA (0.44)
SCHEMBL7434068 0.79 GAA (0.52)
SCHEMBL27884500 0.79 GAA (0.43)
SCHEMBL18048520 0.79
SCHEMBL536155 0.79
SCHEMBL855001 0.78 EPHX1 (0.52)
SCHEMBL8621497 0.78 GAA (0.42)
SCHEMBL16440121 0.78 GAA (0.42)
SCHEMBL19931511 0.78 GAA (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230399281-A1 METHOD FOR PERFORMING MITSUNOBU REACTION BETWEEN ALCOHOLIC HYDROXYL GROUP DONOR AND ACTIVE HYDROGEN DONOR JIANGSU HECHENG ADVANCED MATERIALS CO., LTD. (CN) 2023-12-14 US disclosed
EP-3890491-A1 COMPOSITIONS AND METHODS FOR REDUCING PESTICIDE-INDUCED PLANT DAMAGE AND IMPROVING PLANT YIELD Cytozyme Laboratories, Inc. (US) 2021-10-13 EP disclosed
WO-2020118278-A1 COMPOSITIONS AND METHODS FOR REDUCING PESTICIDE-INDUCED PLANT DAMAGE AND IMPROVING PLANT YIELD CYTOZYME LABORATORIES, INC. (US) 2020-06-11 WO disclosed
US-9732145-B2 Antibodies directed to Bacillus anthracis protective antigen The Israel Institute of Biological Research (IIBR) (IL) 2017-08-15 US disclosed
US-20160289277-A1 COMPOSITIONS AND METHODS FOR SUPPRESSION OF INHIBITOR FORMATION AGAINST COAGULATION FACTORS IN HEMOPHILIA PATIENTS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. 2016-10-06 US disclosed
US-9441032-B2 Binding molecules against Chikungunya virus and uses thereof AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2016-09-13 US disclosed
US-9303264-B2 Photosynthetic microorganisms expressing thermostable lipase THE ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2016-04-05 US disclosed
US-20150361460-A1 METHODS, REAGENTS AND CELLS FOR BIOSYNTHESIZING COMPOUNDS INV NYLON CHEMICALS AMERICAS, LLC 2015-12-17 US disclosed
US-20150353991-A1 MIRNA TARGETS CHILDREN'S MEDICAL CENTER CORPORATION 2015-12-10 US disclosed
EP-2937378-A1 LOW CRYSTALLINITY SUSCEPTOR FILMS Graphic Packaging International, Inc. (US) 2015-10-28 EP disclosed
US-7759343-B2 Pyrrolo-triazine aniline compounds useful as kinase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2010-07-20 US disclosed
US-20090105243-A1 Pyrrolo-Triazine Aniline Compounds Useful As Kinase Inhibitors BRISTOL-MYERS SQUIBB COMPANY 2009-04-23 US disclosed
US-7462616-B2 Pyrrolo-triazine aniline compounds useful as kinase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2008-12-09 US disclosed
US-20080103090-A1 Human Secreted Proteins HUMAN GENOME SCIENCES, INC. (US) 2008-05-01 US disclosed
US-20070055056-A1 251 human secreted proteins HUMAN GENOME SCIENCES, INC. 2007-03-08 US disclosed
US-20070043053-A1 Pyrrolo-triazine aniline compounds useful as kinase inhibitors BRISTOL-MYERS SQUIBB COMPANY 2007-02-22 US disclosed
US-20070015271-A1 Human secreted proteins HUMAN GENOME SCIENCES, INC. 2007-01-18 US disclosed
US-7160883-B2 Pyrrolo-triazine aniline compounds useful as kinase inhibitors BRISTOL-MYERS-SQUIBB COMPANY (US) 2007-01-09 US disclosed
WO-2003018577-A1 ANTIVIRAL NUCLEOSIDE DERIVATIVES AND PROCESS FOR PREPARING THE SAME POSTECH FOUNDATION (KR) 2003-03-06 WO disclosed
US-4076938-A Process for the production of 3-hydroxy-1,2,4-triazole derivatives CIBA-GEIGY CORPORATION (US) 1978-02-28 US disclosed